X
Gilead preps filing for hepatitis D therapy Hepcludex in US
https://pharmaphorum.com/news/gilead-preps-filing-for-hepatitis-d-therapy-hepcludex-in-us/
Hepatitis
US judge overturns Gilead $2.54bn patent infringement ruling
Federal judge throws out Merck’s patent claim against Gilead
NICE recommends MSD’s hep C pill
Cost-effectiveness body backs combination drug Zepatier.
After 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?
Roche’s MS drug is among major drugs still to come in 2016.
Move to eradicate viral hepatitis
NOhep campaign supports action against hepatitis.
Gilead’s latest hep C therapy approved in EU
Firm hopes Epclusa will give an edge over rivals.
1 2